Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$304K Hold
2,362
0.26% 82
2026
Q1
$284K Hold
2,362
0.26% 86
2025
Q4
$249K Sell
2,362
-239
-9% -$22.4K 0.23% 88
2025
Q3
$218K Hold
2,601
0.21% 97
2025
Q2
$206K Hold
2,601
0.22% 96
2025
Q1
$233K Sell
2,601
-15
-0.6% -$1.4K 0.26% 79
2024
Q4
$260K Buy
+2,616
New +$270K 0.3% 77

Other funds holding MRK

North Forty Two & Co's MRK Position: Q2 2026 in Review

North Forty Two & Co held its Merck (MRK) position steady in Q2 2026 at 2,362 shares worth $304K. The position accounts for 0.26% of the portfolio, ranked #82.

North Forty Two & Co first reported a position in MRK in Q4 2024 and has held it in 7 quarters since. 2,083 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • North Forty Two & Co held 2,362 shares of Merck worth $304K as of Q2 2026.
  • North Forty Two & Co left its Merck share count unchanged in Q2 2026.
  • Merck made up 0.26% of North Forty Two & Co's portfolio in Q2 2026, its #82 holding.
  • North Forty Two & Co first reported a position in Merck in Q4 2024 and has held it in 7 quarters since.
  • 2,083 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on North Forty Two & Co's 13F filing for Q2 2026, filed 24 Jul 2026.